This pharmaceutical stock rallied over 220% in the last two years!
Last Updated: 16th December 2022 - 03:27 pm
An investment of Rs 1 lakh in this stock two years ago would have tripled to Rs 3.24 lakh today.
Suven Pharmaceuticals Ltd, an S&P BSE 500 company, has given its investors multibagger returns in the last two years. This pharmaceutical company’s share price has steadily appreciated by 224%, going from Rs 161.68 apiece on 21 May 2020 to Rs 524.30 apiece on 20 May 2022.
Suven Pharmaceuticals Ltd is engaged in the business of contract development & manufacturing organization (CDMO). The company operates in two segments- Active Pharmaceutical Ingredients (APIs) and Intermediates.
In April last month, the company acquired a 100% stake in Casper Pharma Private Limited (CPPL) a Hyderabad based SEZ company engaged in the formulations business. The rationale of this acquisition was to acquire the formulations facility of Casper Pharma and to engage in manufacturing and supplying solid oral dosage formulations including tablets, capsules and liquid oral products through the contractual arrangement with customers for USA and other regulated markets.
Speaking about its financial performance, in the recent quarter Q4FY22, on a consolidated basis, the company clocked a revenue of Rs 363.85 crore, a growth of 40% YoY. The PBIDT (ex OI) grew 67% YoY to Rs 157 crore whereas the PAT grew 42% YoY to Rs 91.67 crore.
Segment-wise, the CDMO Pharma business grew by 52% YoY and generated a revenue of Rs 209 crore. The CDMO specialty chemicals segment grew 25% YoY and clocked a revenue of Rs 136 crore. The remaining Rs 18 crore came from the formulations & other services.
On the valuations front, the company is currently trading at a TTM PE of 29.41x, as against the industry PE of 31.66x. In FY22, the company delivered an ROE & ROCE of 27% and 40.6%, respectively. ]
At 12.15 pm, the shares of Suven Pharmaceuticals Ltd were trading at Rs 523.40, a decrease of 0.17% from the previous closing price of Rs 524.30 on BSE. The stock has a 52-week high & low of Rs 631.15 and Rs 457 respectively on BSE.
Trending on 5paisa
02
5paisa Research Team
03
5paisa Research Team
Discover more of what matters to you.
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.